The reported patterns of trophectodermal expression of POU5F1 protein in blastocysts vary among species, and are possibly related to the differences in placental growth and function. This study investigated the pattern of embryonic POU5F1 expression in the horse, a species with delayed placental formation. Immature equine oocytes expressed POU5F1 protein in the cytoplasm and nucleus. Staining for POU5F1 protein in in vitro-produced (IVP) embryos decreased to day 5 of culture, then the nuclear staining increased to day 7. IVP day-7 to -11 blastocysts showed POU5F1 staining in nuclei throughout the blastocysts. In contrast, in vivo-produced day-7 to -10 blastocysts showed greatly reduced trophoectodermal POU5F1 protein expression. To determine whether the uterine environment modulates POU5F1 expression, IVP blastocysts were transferred to the uteri of mares, then recovered 2-3 days later (IVP-ET embryos). These embryos showed similar POU5F1 expression as the in vivo-produced embryos. Levels of POU5F1, SOX2, and NANOG mRNA in IVP-ET blastocysts were significantly higher in the inner cell mass than in trophectoderm (TE) cells. These data suggest that the differentiation of equine TE, as indicated by loss of POU5F1 expression, is impaired during in vitro culture, but proceeds normally when the embryos are exposed to the uterine environment. Previously reported differences in trophectodermal expression of POU5F1 among species may thus be in part artifactual, i.e. related to in vitro culture. Failure for correction of such changes by the uterine environment is a potential factor in the placental abnormalities seen after transfer of cultured embryos in some species.
Introduction
POU5F1 (previously known as Oct3 and Oct4) is an essential transcription factor involved in regulating early embryonic development and cell differentiation, and was first investigated in the mouse (Scholer et al. 1989b) . POU5F1 is expressed in pluripotent cells, including embryonic stem cells and cells of the inner cell mass (ICM) of blastocysts, and is important for the maintenance of pluripotency. Spontaneous or induced loss of pluripotency is associated with loss of POU5F1 expression (Scholer et al. 1989a , Buehr et al. 2003 . The capacity of cloned blastocysts to form embryonic lineages is reduced if inappropriate levels of Pou5f1 expression are present in the ICM (Boiani et al. 2002) . In Pou5f1 knockout mice, the ICM forms but the cells are not pluripotent; they differentiate along the trophoblast lineage (Nichols et al. 1998 ).
The pattern of POU5F1 expression during early embryo growth appears to differ among species. In most species, maternal POU5F1 protein may be found in oocytes and early embryos, and embryonic protein first appears at the 4-to 16-cell stage (Palmieri et al. 1994 , Mitalipov et al. 2003 , Cauffman et al. 2005 . In mice and rhesus monkeys, by the expanded blastocyst stage the protein becomes isolated in the ICM and is absent from the trophectoderm (TE; Scholer et al. 1990 , Mitalipov et al. 2003 . Protein expression patterns are similar to the expression patterns of POU5F1 mRNA during preimplantation development. By contrast, in cattle and swine embryos, the pattern of POU5F1 expression in the blastocyst is reported to differ, it is found in both the TE and ICM (van Eijk et al. 1999 , Kirchhof et al. 2000 . POU5F1 mRNA expression in bovine blastocysts is unclear; it has been reported to be only in the ICM (Kurosaka et al. 2004) , or in both the ICM and TE (Degrelle et al. 2005) . Similarly, there is some question on the expression of POU5F1 mRNA in human blastocysts. Some authors report that POU5F1 protein and mRNA are found in both the ICM and the TE (Cauffman et al. 2005) ; however, others have found that POU5F1 mRNA expression is limited to the ICM, both by PCR and by expression profiling (Hansis et al. 2000 , Adjaye et al. 2005 . Chen et al. (2009) found that POU5F1 was expressed in the TE and ICM of 5-day-old human blastocysts (40-75 cells), but was restricted to the ICM in 6-day-old blastocysts (75-145 cells) .
The apparent variability in presence of POU5F1 protein and/or mRNA in the TE among species have raised questions as to the role of POU5F1 in maintaining or signaling pluripotency. In the mouse, POU5F1 is co-expressed and interacts with the TE-specific Cdx2 (previously known as Cdx3) gene product, and their relative levels determine whether a cell remains pluripotent (i.e. ICM) or becomes TE (Niwa et al. 2005) , and thus differentiates to form extraembryonic tissues. It has been suggested (Kirchhof et al. 2000 , Kurosaka et al. 2004 ) that the variability in loss of expression of POU5F1 in trophectodermal cells among species is related to the time of onset of functional placentation; i.e. early in the mouse (w4 days) but late in the bovine (w17 days). However, POU5F1 expression as seen in human embryos seems to confound this hypothesis: the TE of morphologically normal human embryos has been reported to express POU5F1 (Cauffman et al. 2005) , but the human embryo has a time course of implantation similar to that of the mouse. Degrelle et al. (2005) put forward an alternative hypothesis, i.e. that POU5F1 transcripts remained in the bovine TE through the ovoid stage to support the rapid cell multiplication needed for trophoblast elongation.
Examination of additional species may help to define the relationship between trophectodermic POU5F1 expression and the time of onset of placentation. The horse is an exceptional mammal in which functional placentation is extremely delayed, to after 40 days of gestation (van Niekerk & Allen 1975) . Actual physical contact of the TE with the endometrium does not occur until after the embryonic capsule dissolves, around day 20. The pattern of POU5F1 protein expression during embryo development has not been described in the horse. In one report, POU5F1 expression appeared to be restricted to the ICM of day 7 in vivo-recovered equine blastocysts (Guest & Allen 2007) . POU5F1 protein staining and POU5F1 RT-PCR have been demonstrated in equine ES-like cells (Saito et al. 2002 , Li et al. 2006 , Guest & Allen 2007 .
In horse embryos, events surrounding differentiation of the trophoblast have not been well described. It appears that the blastocoel forms within the transitioning morula/blastocyst in a multicentric manner, resulting in a loose network of inner cells within a defined trophectodermal rim; this has been demonstrated in both in vitro-produced (IVP) equine embryos (Hinrichs et al. 2007b ) and in early equine blastocysts recovered ex vivo (Bruyas et al. 1993 , Grondahl et al. 1993 , Tremoleda et al. 2003 . This differs from the asymmetric cavitation process observed in mouse blastocysts (Wiley & Eglitis 1980) . Enders et al. (1993) reported that in equine embryos, some of these inner network cells migrate directly to the inner aspect of the TE and proliferate to form the endodermal cell layer; although not described, it appears that other inner cells coalesce to form the ICM.
In this study, we evaluated the pattern of POU5F1 expression during early equine embryo development in vitro, in blastocysts recovered from the uteri of mares ex vivo, and in IVP blastocysts transferred to the uterus and then recovered (IVP-ET).
Results
Photomicrographs of representative oocytes are presented in Fig. 1 . Immature oocytes showed POU5F1 staining in the nucleus and cytoplasm. The POU5F1 staining within the nucleus delineated the outline of the germinal vesicle (GV) in oocytes having diffuse to condensed chromatin (the latter being the chromatin configuration found in meiotically competent horse oocytes; Hinrichs et al. 2005) . Metaphase II oocytes showed POU5F1 staining in the cytoplasm.
Photomicrographs of representative IVP embryos on the different days of culture are presented in Fig. 2 . A total of 65 day-1 to -7 embryos were stained for POU5F1, and 23 embryos (a minimum of three embryos at each day of culture; excluding day 6) were used for analysis of pixel intensity. The numbers of nuclei used for selection of embryos for assessment were: 2 (or 2 pronuclei), 4, 6, 12, and 40 for days 1-5 respectively. The three day 6 morulae evaluated contained 52, 83, and O150 nuclei. Pixel intensity of day-6 embryos was not included in the statistical analysis; nuclei of these embryos stained strongly, and compaction of the morulae led to inadequate spreading of the embryo on the slide to separate the nuclei (Fig. 2 ). Embryos stained with secondary antibody alone (no primary antibody) exhibited no fluorescence (Fig. 2) .
In day-1 pronuclear zygotes and in early cleavage stage embryos (1-2 days, 2-6 cells), cytoplasm and nuclei showed clear staining for POU5F1 protein. POU5F1 expression in both nucleus and cytoplasm decreased significantly at day 3, being lowest at day 5. From 5 to 7 days (40 cells to blastocyst), POU5F1 protein staining intensity increased significantly within the nuclei but stayed low in the cytoplasm.
In day-7 to -8 IVP blastocysts, staining for POU5F1 protein was restricted to the nuclei (Fig. 3) . Nuclear staining was seen throughout the blastocyst; there was no difference in pattern for POU5F1 or DAPI staining that could be used to delineate the ICM from the TE in any of the IVP blastocysts evaluated. The majority of the nuclei within the blastocysts showed POU5F1 expression; however, a few scattered nuclei did not. Zona removal and additional culture for 3 days allowed blastocyst expansion in vitro; embryo diameters increased from a mean (GS.E.M., including zona) of 166.8G2.8 and 168.6G3.3 mm for IVP blastocysts first seen at day 7 and 8 respectively, to 239.1G26.6 and 410.9G47.4 mm (exclusive of zona) at day 10 and 11 respectively. Similarly, embryo cell number increased from an average of 294G39 for day-7 IVP blastocysts to 1205G84 for day-10 blastocysts, and 3378 for a day-11 blastocyst. A photomicrograph of a day-11 IVP embryo is presented in Fig. 4 . Increased duration of culture was not associated with a change in POU5F1 protein expression, as nuclear staining continued to be seen throughout these embryos (Fig. 3) , and staining intensity in day-10 and -11 blastocysts did not differ significantly from that for day-7 or -8 blastocysts (mean nuclear pixel intensities of 42.3G4.9 and 43.6G5.4 respectively).
In contrast, in vivo-produced blastocysts recovered at days 7-10 had vivid expression of POU5F1 protein in the ICM, and only limited expression in the TE (Fig. 3) . Trophectodermal nuclear staining in in vivo-produced embryos decreased significantly as the embryo diameter increased. The mean pixel intensity (GS.E.M.) in photomicrographs of TE from in vivo-produced embryos !500 mm in diameter (nZ3) or O600 mm (nZ4), taken on the same standard exposure as above, were 13.98 G3.59 and 1.53G1.58 respectively (PZ0.01). The larger blastocysts showed expression of POU5F1 protein exclusively within the ICM (Fig. 3) . Total cell numbers of in vivo-derived embryos having diameters of 322, 428, and 446 mm were 1598, 2162, and 1782 respectively. To address whether the uterine environment has an influence on POU5F1 expression, we next transferred early blastocysts derived by IVP to recipient mares and subsequently flushed these out for analysis 2-3 days later. After transfer of 29 IVP embryos, 22 embryos, designated IVP-ET embryos, were recovered (Fig. 5 ). All recovered blastocysts had formed an embryonic capsule. Three IVP-ET embryos were lost during shipment to the laboratory; six embryos were used for POU5F1 immunostaining, four embryos were used for RT-PCR, and nine embryos were used for a separate study.
Out of six IVP-ET embryos stained for POU5F1 protein and evaluated on the same standard exposure as above, one embryo recovered at age day-8 or -9 (recovered from a mare that received both day-6 and -7 embryos), diameter 453 mm, had POU5F1 expression in the trophectodermal nuclei similar to that for in vivoproduced embryos of the same diameter (pixel intensity 15.31). An additional day-10 embryo, 787 mm in diameter, had a pixel intensity of 2.1 in the trophectodermal nuclei. The remaining day-10 embryos (nZ4; O1000 mm in diameter) all had a trophectodermal nuclear pixel intensity of !1 (Fig. 3) . The pixel intensity of ICM nuclei in the six IVP-ET embryos (meanGS.E.M) was 38.33G8.43. Figure 6 is a composite photomicrograph of the entire ICM of an IVP-ET blastocyst, showing the vivid difference in staining between the ICM and the surrounding TE.
Four IVP-ET blastocysts, O600 mm in diameter, were dissected into ICM and TE segments and were used for quantitative RT-PCR of POU5F1, SOX2, NANOG, and CDX2 expression. The values of mRNA expression in the ICM and the TE are shown in Fig. 7 . The values for TE Figure 3 Equine blastocysts immunostained for POU5F1 protein (Cy3 fluorescent label) and counterstained with DAPI. Even though nuclei appear to be of different sizes, all photomicrographs are presented at the same photographic magnification and exposure. Bar represents 50 mm. IVP, fertilized by ICSI and cultured in vitro; in vivo-produced, conceived in vivo and flushed from the uterus at the given day after ovulation; IVP-ET, fertilized by ICSI, cultured in vitro to the blastocyst stage, then transferred to the uterus of a recipient mare and flushed from the uterus 2-3 days after transfer. Figure 4 Light micrograph of a day-11 IVP embryo, 484 mm diameter. This embryo was produced by ICSI of an in vitro-matured oocyte followed by culture in vitro; it formed a blastocyst at day 8, had the zona removed at that time, and was cultured an additional 3 days to allow blastocyst expansion. Bar represents 100 mm. are shown as the average of two TE fragments in each embryo. Levels of mRNA in relation to b-ACTIN in the tissue section containing the ICM were significantly higher than in the TE (P!0.05) for POU5F1, SOX2, and NANOG, but there was no difference between tissue types for CDX2.
When the expression of mRNA for POU5F1, SOX2, NANOG, and CDX2 was evaluated in whole IVP embryos harvested either at the time of blastocyst formation (day-7 or -8) or after zona removal at the time of blastocyst formation and continued culture in vitro until day 10, only NANOG showed a significant difference between these embryo types (average NANOG/b ACTIN ratio of 0.14G0.03 vs 0.02G0.01 for early blastocysts versus day-10 blastocysts respectively; P!0.05). Overall, expression of mRNA in relation to b-ACTIN for all four genes evaluated was 10-fold higher in IVP embryos than in IVP-ET embryos.
Discussion
The results of this study show that POU5F1 protein is present in the cytoplasm and nucleus of immature equine oocytes, decreases during embryo development to day 5, then increases again within embryonic nuclei. The decrease in POU5F1 staining over the first 5 days of embryo development reflects a depletion of maternal stores of protein and mRNA; the increase in expression after day 5 suggests the onset of transcription of this gene from the embryonic genome. This pattern is similar to that reported for POU5F1 expression in other species, with the exception that the re-emergence of POU5F1 in the horse embryo occurred at a later stage of development -at day 6, when these embryos had 50-150 nuclei, rather than at the 4-to 16-cell stage as in other species (Palmieri et al. 1994 , Mitalipov et al. 2003 , Cauffman et al. 2005 . The time of onset of embryonic transcription in equine embryos is not well established, but appears to start after the 4-cell stage (Grondahl et al. 1993 , Brinsko et al. 1995 .
Expression of POU5F1 within the nucleus of oocytes having condensed chromatin demonstrates that this chromatin configuration represents a GV stage oocyte, as has been previously demonstrated after oocyte centrifugation (Hinrichs et al. 1993) . This chromatin configuration is categorized by some laboratories as representing GV breakdown (Torner & Alm 1995) . Staining for POU5F1 protein was not found in the GV of mouse or monkey oocytes (Mitalipov et al. 2003 , Chang et al. 2005 . It was notable that while POU5F1 was concentrated in the nucleus of immature equine oocytes, it was not associated with the chromatin in these oocytes (Fig. 1) . Since POU5F1 is a transcription factor, it is plausible to suggest that maternally-derived POU5F1 is not biologically active within the oocytes of antral follicles, probably because little transcription of Figure 6 POU5F1 expression of the entire inner cell mass of an IVP-ET equine blastocyst (transferred to the uterus on day 7 and recovered on day 10). Eight overlapping photomicrographs were combined to synthesize each picture. Bar represents 50 mm. POU5F1-regulated genes is taking place, whereas POU5F1 is actively affecting transcription within the developing embryo (Cauffman et al. 2005) . The finding that POU5F1 is expressed in the TE of equine blastocysts produced in vitro, but is suppressed in TE of embryos recovered from the uterus (either produced in vivo or transferred after in vitro production) suggests that the in vitro environment does not support equivalent equine blastocyst development to that seen in vivo and that the uterine environment is required for POU5F1 suppression and thus differentiation of the TE in the horse. The lack of normal POU5F1 signaling observed in equine embryos in vitro may explain the failure of the embryonic capsule to form in cultured equine embryos (McKinnon et al. 1989 , Tremoleda et al. 2003 , Choi et al. 2004 , and underlie the apparent failure of allocation of internal cells to ICM and endoderm in these embryos (Hinrichs et al. 2007b) .
Exposure of day-7 IVP equine blastocysts to the uterine environment for 2-3 days resulted in apparently normal reduction of POU5F1 protein expression in the TE. Findings on RT-PCR of ICM and trophectodermal tissue of IVP-ET embryos indicated that the decreased POU5F1 protein content of the TE was associated with significantly lower mRNA expression in the TE than that in the ICM, and thus is not due to simple degradation of translated protein in the TE. Suppression of POU5F1 in the TE of these embryos coincided with formation of a capsule and well-defined ICM within the 2-or 3-day-period of uterine exposure. Such IVP equine blastocysts go on to produce normal foals (Hinrichs et al. 2007b ) and recently yielded a 71% normal pregnancy rate after transfer (12/17; unpublished data). The pluripotency genes SOX2 and NANOG had significantly higher expressions in the ICM than in the TE of IVP-ET embryos, with SOX2 showing the greatest specificity to the ICM. By contrast, the TE-specific gene CDX2 was expressed similarly in both ICMcontaining and TE fragments. This latter finding is expected as the fragment containing the ICM also contained adjacent TE cells. No CDX2 expression was found in immunodissected ICM of human blastocysts evaluated by expression profiling (Adjaye et al. 2005) . To our knowledge, these findings represent the first evaluation of POU5F1 gene expression in horse embryos, and the first analysis of SOX2 and NANOG gene expression in any equine tissue. Relative expression of all evaluated genes was 10-fold higher in IVP embryos than in in vivoproduced embryos. This may be related to variation in expression of the housekeeping gene, b-ACTIN, in IVP embryos, as has been previously shown for other housekeeping genes in bovine embryos (Ross et al. 2009) .
While many studies have been done comparing overall POU5F1 mRNA expression between in vitroand in vivo-produced embryos in other species, little information is available on the effect of in vitro culture on differential distribution of POU5F1 expression in the TE and ICM. Both in vitro-cultured and in vivo-recovered mouse embryos appear to suppress POU5F1 expression in the TE as the blastocyst expands (Rosner et al. 1990 , Palmieri et al. 1994 , Mitalipov et al. 2003 . In contrast, it is thought that POU5F1 protein is not suppressed in the TE of bovine embryos in vivo or in vitro. This understanding is based largely on the findings of van Eijk et al. (1999) and Kirchhof et al. (2000) . There are some areas of confusion in these reports; however, van Eijk et al. (1999) found POU5F1 protein immunostaining in ICM and TE of IVP and oviductal embryos, but no POU5F1 protein immunostaining at all in uterine embryos examined at days 14 and 16. This latter finding is in contrast to that of Vejlsted et al. (2005) , who reported POU5F1 protein immunostaining in the epiblast, but not TE, of day 12 and 14 uterine bovine embryos. Kirchhof et al. (2000) examined both in vivo-and in vitro-derived bovine and porcine blastocysts and reported POU5F1 immunostaining in both cytoplasm and nucleus throughout the TE and ICM in embryos of both species. By contrast, Vejlsted et al. (2006) evaluated in vivo-derived day 8 porcine blastocysts and found immunostaining confined to the ICM, and only in nuclei. One possible explanation for the overall staining reported by Kirchhof et al. (2000) is that the polyclonal antibody used in that study may have recognized a splice variant of POU5F1 (Oct3B). This variant is found in humans, but not in mice, and is present in both cytoplasm and nucleus of human blastocysts (Cauffman et al. 2005) . Confusion also exists on the level of POU5F1 mRNA expression in bovine spherical (day 7) blastocysts; Kurosaka et al. (2004) found clear loss of mRNA from TE of expanded IVP blastocysts, whereas Degrelle et al. (2005) found mRNA expression in TE of both expanded IVP blastocysts and in vivo-derived later ovoid blastocysts, even though these authors note that Vejlsted et al. (2005) found differential POU5F1 protein expression in ovoid embryos. Unfortunately, no data on POU5F1 protein was given in the studies of Kurosaka et al. (2004) or Degrelle et al. (2005) . From these data, it appears that the degree of expression of POU5F1 in the TE of bovine blastocysts, either in vivoor IVP, has not been clearly defined.
A difference in trophectodermal POU5F1 expression pattern between in vitro-and in vivo-produced embryos has been described in the goat (He et al. 2006) . In that report, in vitro-derived goat embryos had lower, and more scattered, trophectodermal expression of POU5F1 than in vivo-derived embryos did, findings which are opposite to ours in the horse. If, as hypothesized by Degrelle et al. (2005) POU5F1 expression in ruminant embryos is necessary to maintain cellular capacity for rapid elongation, this failure of POU5F1 maintenance in the goat embryonic TE in vitro has the potential to compromise development after transfer.
Our findings of reduced POU5F1 expression in the horse TE in vivo are compatible with the hypothesis of Degrelle et al. (2005) in the relationship of continued POU5F1 expression to capacity for elongation, rather than with earlier theories that continued trophectodermal POU5F1 expression is associated with a longer time to onset of placental function. The equine conceptus does not undergo a period of rapid elongation, but does have a greatly delayed time to placental function. The equine conceptus enlarges spherically at the base of one uterine horn until 40 or more days of gestation. During this period there is minimal placental interdigitation with the endometrium, and the embryo relies on uterine secretions for sustenance (review, Ginther 1992) . However, if the findings of Vejlsted et al. (2006) in in vivo-derived day 8 porcine blastocysts are accurate, rapid elongation occurs in pig TE in the absence of trophectodermal POU5F1.
It is important to determine if culture-induced failure of normal trophectodermal POU5F1 regulation occurs in other species, and if so, to what extent exposure to the uterus returns the TE to a normally differentiated state, as appears to occur in the horse. Many reports on POU5F1 expression patterns in blastocysts, including those evaluating human embryos (Hansis et al. 2000 , Cauffman et al. 2005 ) have utilized only IVP embryos. Our results indicate that POU5F1 expression in the TE of equine blastocysts is an artifact of culture. It is likely that different culture environments may affect POU5F1 mRNA or protein expression differently, and if so, this may be associated with variations in findings as evident among laboratories working in the same species. Further work is needed before conclusions on the role of POU5F1 in pluripotency are drawn from studies of IVP embryos.
It is possible that culture-induced changes in trophectodermal POU5F1 expression may be related to the placental abnormalities found after transfer of embryos in some species under certain culture conditions, e.g. large offspring syndrome. The horse appears not to suffer from this syndrome; it has not been reported after transfer of either IVP (Galli et al. 2007 , Hinrichs et al. 2007b or nuclear transfer embryos , Hinrichs et al. 2006 , 2007a . However, we found in the present study that transfer of IVP equine embryos to the uterus resulted in normalized expression patterns. If aberrant or asynchronous trophoectodermal POU5F1 expression continued after transfer of IVP blastocysts, it could impair trophectodermal differentiation and subsequent formation of extraembryonic tissues. Cannabinoid-induced persistence of POU5F1 expression in the TE of expanded mouse blastocysts has been associated with compromised development to term (Wang et al. 2006 ).
Materials and Methods

Oocytes and embryos evaluated
A total of 10 immature and 10 metaphase II oocytes, and a minimum of 8 IVP embryos at each of day 1 through 7 of culture, were processed for immunocytochemistry to detect POU5F1 protein. IVP embryos were obtained via ICSI of in vitro-matured oocytes. Only those embryos in the top 50% of nucleus number (disregarding degenerating nuclei) for embryo age were included in the analysis.
A total of 20 additional IVP blastocysts (days 7-8 of culture) were evaluated by immunocytochemistry, and 7 IVP blastocysts that were subjected to removal of the zona pellucida on day 7 or 8 of culture, followed by culture for an additional 3 days. The equine zona pellucida does not thin normally in culture , so removal of the zona is necessary to allow blastocyst expansion in vitro.
POU5F1 protein in in vivo-produced embryos was evaluated by immunocytochemistry of blastocysts (nZ7) obtained by uterine flush of inseminated mares 7-10 days after ovulation.
To evaluate the effect of the uterine environment on POU5F1 expression, day-6 or -7 IVP blastocysts were transferred to the uteri of recipient mares and recovered 2-3 days later (IVP-ET embryos). These embryos were subjected to either immunocytochemistry for POU5F1 protein (nZ6) or to RT-PCR for POU5F1, SOX2, NANOG, and CDX2 mRNA (nZ4). Six additional IVP embryos were generated by ICSI of oocytes recovered from mares ex vivo. Three of these embryos were harvested for analysis of POU5F1, SOX2, NANOG, and CDX2 mRNA as soon as they were seen to be blastocysts (day-7 or -8), and three underwent zona removal at the time they formed blastocysts, were cultured until day 10, then were subjected to RT-PCR.
IVP embryos
Equine ovaries were obtained from an abattoir and were transported for 3-4 h at room temperature to the laboratory, where the oocytes were collected, classified, and matured in vitro as previously described (Choi et al. 2002) . Oocyte-cumulus complexes were classified as compact or expanded depending on the expansion of both mural granulosa and cumulus as previously described (Hinrichs et al. 2005) . Recovered expanded and compact oocytes were matured in tissue culture medium (TCM)-199 with Earle's salts (Invitrogen Corp.) plus 10% fetal bovine serum (FBS; Invitrogen), 5 mU/ml FSH (Sioux Biochemicals Inc., Sioux Center, IA, USA) and gentamycin (25 mg/ml; Invitrogen) in droplets at a ratio of 10 ml medium/oocyte under light white mineral oil (Sigma Chemical Co.) at 38.2 8C in 5% CO 2 in air. Expanded oocytes were cultured for 24 h; compact oocytes for 30 h (Hinrichs et al. 2005) .
To generate additional ICSI/in vitro-cultured embryos for PCR studies, oocytes were recovered from mares ex vivo. Quarterhorse type mares, aged 3-18 years and weighing 400-500 kg, were maintained in paddocks with run-in sheds, and were fed hay and sweet feed with free-choice water. Work with these mares was performed according to the United States Government Principles for the Utilization and Care of Vertebrate Animals Used in Testing, Research and Training and was approved by the Laboratory Animal Care Committee at Texas A&M University. Oocytes were recovered either by aspiration of the dominant pre-ovulatory follicle after gonadotropin stimulation (Hinrichs et al. 1998) , or by aspirating all visible follicles on the ovary via transvaginal ultrasoundguided aspiration as described by Duchamp et al. (1995) . Oocytes were recovered from pre-ovulatory follicles 24 h after gonadtropin stimulation, then cultured for 16-20 h in TCM-199 with Earle's salts and 10% FBS before ICSI; oocytes recovered by transvaginal aspiration of immature follicles were matured in vitro, as described above, before being subjected to ICSI. The ICSI procedure was conducted as we have previously described (Choi et al. 2002 (Choi et al. , 2003 . Briefly, after maturation, oocytes were denuded of cumulus by pipetting in 0.05% hyaluronidase and those with a polar body were used for ICSI. Sperm from frozen-thawed equine semen was prepared by swim-up. One microliter of sperm suspension was placed on the surface of a 3 ml droplet of Sp-Chatot, Ziomek, Bavister (CZB) (Choi et al. 2003) containing 10% polyvinylpyrrolidone. The sperm were injected into the oocyte cytoplasm using a Piezo drill.
Embryo culture was performed in microdroplets of DMEM/F-12 medium (Sigma) with 10% FBS and 25 mg/ml gentamycin under light white mineral oil at a ratio of 1 ml medium per embryo, in an atmosphere of 5% CO 2 , 5% O 2 , and 90% N 2 at 38.2 8C; this protocol has been shown to support high rates of equine in vitro blastocyst production (Hinrichs et al. 2005) . Medium was changed every 2-3 days. At 7-8 days culture, embryos were classified as blastocysts if they showed organization of an outer ring of presumptive TE cells (Choi et al. 2004) .
Removal of the zona pellucida of selected blastocysts was performed by placing the embryo into 3 ml acid Tyrode's solution (pH 2) and monitoring the embryo under the dissection microscope. When the zona pellucida started to dissolve, the embryo was removed from the Tyrode's solution and washed thrice in DMEM/F-12 with 20% FBS, during which time the zona was shed. The embryo was then placed back into 0.5 ml of DMEM/F-12 with 20% FBS in a well of a 4-well multidish (Nunc, Roskilde, Denmark) under oil in the culture environment described above.
In vivo-produced and IVP-ET embryos
The research mares described above were utilized for embryo collection and transfer; in addition, embryos were shipped to and from a commercial embryo transfer facility (Hartman Equine Reproduction Center, Whitesboro, TX, USA). Use of the mares at this facility was reviewed and approved by the Clinical Research Review Committee, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University.
To obtain in vivo-produced embryos, mares' follicular development was monitored by palpation and ultrasonography per rectum. When the dominant follicle was O30 mm in diameter, mares were administered biorelease deslorelin (1.5 mg, i.m; BET Pharm, Lexington, KY, USA) and were artificially inseminated with fresh, extended semen containing a minimum of 500!10 6 motile sperm. Ultrasonographic monitoring was continued to detect the day of ovulation (day 0). Embryos were recovered from the mares by uterine flush on day 7-10 after ovulation as previously described (Hinrichs 1990) .
To obtain IVP-ET embryos, 29 IVP blastocysts (1 from day-6 and 28 from day-7) were transferred transcervically to the uteri of recipient mares that had ovulated from 1 day before to 4 days after the date of ICSI. The mares' uteri were flushed 2-3 days after the transfer to recover embryos. When embryos were shipped to the transfer facility, they were placed in 1.1 ml of equilibrated DMEM/F-12 with 10% FBS in a glass vial. This vial was wrapped in 120 ml ballast at 38.2 8C, placed in a shipping container (Equitainer, Hamilton Research Inc. South Hamilton, MA, USA) in which the coolant cans had been warmed to 38.2 8C, and shipped 4-6 h before transfer to recipient mares. Embryos recovered from these mares on uterine flush 3 days later were then similarly shipped back to the laboratory for analysis.
Immunocytochemistry
The procedure used for immunocytochemistry was modified from the protocol described by Mitalipov et al. (2003) . The primary antibody was a mouse mAb against amino acids 1-134 of human POU5F1 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA); the secondary antibody was a goat anti-mouse antibody conjugated with indocarbocyanine (Cy3; Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA). The oocytes and embryos were fixed in 4% paraformaldehyde for 20 min. If the embryos or oocytes were not stained on the same day, they were stored in PBS with 2 mg/ml BSA at 4 8C for up to 5 days. The specimens were permeablilized in a mixture of 0.2% Triton X-100 and 0.1% Tween-20 in PBS for 20 min at room temperature. The oocytes/embryos were then rinsed in PBS with 0.1% Tween-20 and placed in a blocking solution of 10% normal goat serum ( Jackson ImmunoResearch) in PBS for 20 min at room temperature, after which they were incubated overnight at 4 8C in the primary antibody (1:200 in PBS). Extensive washing in 0.1% Tween-20 in PBS was performed, followed by administration of the secondary antibody for 40 min at room temperature. Nuclei were counterstained by a 10 min incubation with DAPI at a concentration of 1.5 mg/ml in PBS. The stained oocytes/embryos were mounted on slides under cover slips in ProLong Antifade (Invitrogen), which was allowed to cure overnight before visualization.
The stained oocytes and embryos were evaluated under fluorescence microscopy. For oocytes and embryos up to day 6, the nucleus number for each embryo was determined on evaluation of the DAPI stain. Only normal nuclei were counted; those showing pyknosis or degeneration were disregarded. Only embryos in the top 50% of nucleus number for their day of culture were analyzed to eliminate evaluation of non-viable embryos. Selection of day 7 embryos for analysis was based on classification as blastocysts (embryos having O64 nuclei and an organized outer ring of presumptive trophectodermal cells).
In vivo-produced and IVP-ET blastocysts were first evaluated under light microscopy, and the presence of an identifiable ICM was recorded. They were then stained for presence of POU5F1 protein as described above, and evaluated under fluorescence microscopy to assess the relative intensity of staining of the ICM and trophectodermal nuclei.
Analysis of immunostaining for POU5F1 protein
The intensity of staining for POU5F1 protein was analyzed by evaluating pixel intensity of photomicrographs of immunostained embryos based on the method reported by Lehr et al. (1997) with modifications. It should be noted that pixel intensity may be affected by the changes in nuclear diameter during embryo development and by procedural variations, and thus is an inexact measure of protein content. Using a Zeiss inverted microscope (Carl Zeiss MicroImaging Inc., Thornwood, NY, USA), separate DAPI-and Cy3-stained images at the same focal plane were captured at preset exposure and color intensity settings by an AxioCam MRC5. The image data was transmitted to the software of AxioVision version 4.5 (Carl Zeiss). Images were saved as TIFF files. All images were obtained using a !40 objective.
To measure pixel intensity, images were opened in Photoshop, version 7.0 (Adobe Systems). The DAPI-stained image of an embryo was copied and pasted as a layer on the Cy3-stained image, the blending option for the DAPI image was selected as 50%, the images were aligned, and the DAPI image was again rendered opaque. In embryos up to and including day 5, all nuclei present were selected in the DAPI image. The DAPI image layer was then eliminated and the selected nuclei were evaluated in the layer of the Cy3 image, which was transformed to grayscale. Nuclear pixel intensity was measured using the Histogram tool. Subsequently, the cytoplasm was defined by selecting the inverse to the nuclei, and selecting the entire embryo (outline of cytoplasm within the zona pellucida). The pixel number and intensity of the cytoplasm so selected were measured and recorded. In day-7 and later IVP blastocysts, 20 nuclei appearing in the focal plane were selected in the DAPI image from each embryo, and then evaluated in the Cy3 image as described above. In these embryos, areas of cytoplasm free from underlying nuclei were selected in the DAPI image and evaluated in the Cy3 image to determine cytoplasmic pixel intensity. Background pixel intensity in IVP embryos was measured in each grayscale Cy3 image outside the periphery of the embryo, and this was subtracted from the recorded nuclear or cytoplasmic pixel intensity before analysis.
Intensity of POU5F1 staining in the trophectodermal and ICM nuclei of in vivo-produced and IVP-ET embryos of different sizes was assessed as described above, with 20 nuclei measured for each tissue type. Background pixel intensity for analysis of trophectodermal nuclear POU5F1 staining in these embryos was measured in the cytoplasm. It was not possible to compare nuclear staining pixel intensities of ICM between IVP and in vivo-produced or IVP-ET embryos because of the inability to distinguish the area of the ICM from that of the TE in IVP embryos.
Cell number in in vivo-produced embryos and in IVP blastocysts was calculated by counting cells within a section of a photomicrograph of the embryo, then multiplying this by the total embryo area; this was performed three times for each embryo and the counts averaged.
Real-time RT-PCR analysis in equine blastocysts
POU5F1, SOX2, NANOG, and CDX2 mRNA expression in the ICM and TE of equine blastocysts was quantitated by real-time RT-PCR. Individual IVP-ET blastocysts (nZ4) were dissected into three pieces: one containing the ICM with some adjacent TE, and the other two being approximately equal size fragments of the rest of the blastocyst containing TE only. Whole IVP embryos -three day-7 or -8 blastocysts and three blastocysts subjected to zona removal and cultured until day 10 -were subjected in their entirety for RT-PCR for SOX2, NANOG, and CDX2. Inability to identify the ICM in IVP horse embryos precluded comparison of POU5F1 mRNA expression in TE and ICM between in vitro-cultured and in vivo-recovered embryos. Levels of mRNA were standardized to the level of internal housekeeping gene b-ACTIN in each fragment or embryo.
Real-time RT-PCR was performed on reusable Dynabead Oligo (dT) 25 -cDNA libraries synthesized from samples. Sample collection and RT were performed as previously described (Kurosaka et al. 2004) . Briefly, mRNA captured by Dynabeads (Dynal, Oslo, Norway) was reverse transcribed using the Dynabead-coupled Oligo (dT) 25 as primer resulting in a cDNA library covalently bound to the Dynabeads. After the RT, the first strand cDNA bound to the Dynabeads was used as template for repeated gene-specific second-strand cDNA synthesis. Second strand cDNA was synthesized from each library by performing one PCR cycle (94 8C for 10 s, 52 8C for 20 s, and 72 8C for 20 s) in 10 ml PCR mix (1!LightCycler FastStart DNA Master SYBR Green I (Roche Diagnostics Co.), 3-4 mM MgCl 2 ) containing 2 mM gene-specific forward primers. After denaturation at 95 8C for 1 min, 5 ml of supernatant containing second strand cDNA was added into a glass capillary and mixed with 5 ml PCR mix supplied with 2 mM gene-specific reverse primers, and 40 additional PCR cycles (95 8C for 10 s, 52 8C for 5 s, and 72 8C for 20 s) were performed on a Roche LightCycler Real-Time PCR System. Primers used for amplification were: POU5F1 Forward: 5 0 -CAA GCA GTG ACT ATT CGC AAG-3 0 and Reverse: 5 0 -TGA CAG ACA CAG AGG GAA AGG C-3 0 ; NANOG Forward: 5 0 -CCT CCA TGG AAC TGC TCA TTC-3 0 and Reverse: 5 0 -CAT CTG CTG GAG GCT GAG GT-3 0 ; SOX2 Forward: 5 0 -CGA GTT GAA ACT TTT GTC G-3 0 and Reverse: 5 0 -GGT ATT TAT AAT CCG GGT GCT-3 0 ; CDX2 Forward: 5 0 -GGA GCT GGA GAA GGA GTT TC-3 0 and Reverse: 5 0 -GGA GGG AAG ACA CAG GAC TC-3 0 ; b-ACTIN, Forward: 5 0 -ATG GTG GGA ATG GGT CAG AAG GAC-3 0 and Reverse: 5 0 -CTC TTT GAT GTC ACG CAC GAT TTC-3 0 . The CDX2 primer used was that described by de Mestre et al. (2009) for the horse; primers for equine POU5F1, SOX2, and NANOG were generated by probing the horse genome (Horse Genome Resource Database NCBI: National Library of Medicine, Bethesda, MD, USA. World Wide Web (URL: http://www.ncbi.nlm.nih.gov/projects/genome/guide/horse/)) with known primer sequences for other mammalian species.
Statistical analysis
Recorded pixel intensities of POU5F1-immunostained IVP embryos were transformed to the natural logarithm to provide normal distribution, and one-way ANOVA were performed on the transformed data using SigmaStat 3.0 (Aspire Software International, Ashburn, VA, USA). Multiple comparisons were examined by the Holm-Sidak method. Pixel intensity of nuclei in day-7 or -8 vs day-10 or -11 IVP embryos, and of trophectodermal nuclei in in vivo-produced embryos of different sizes, were compared by Student's t-test on the untransformed measurements. Relative quantification of gene expression was performed using the basic relative quantification algorithm of LightCycler Software (Roche, Version 4), which employs the deltadeltaCT method for calculation, using CT values generated for each amplification curve that crosses background levels. Values for mRNA expression in the ICM and TE of equine blastocysts, and between day-7 or -8 and -10 IVP embryos, were analyzed by paired Student's t-test.
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